The limitations of classical, soluble drugs in terms of subtype-specificity, spatiotemporal precision, and genetic targeting have spurred the development of advanced pharmacological techniques, including the use of covalently-tethered photoswitchable ligands. However, a major shortcoming of tethered photopharmacology is the inability to obtain optical control with a comparable efficacy to the native ligand. To overcome the limitations of photoisomerization efficiency and tethered ligand affinity, we have developed a family of branched photoswitchable compounds to target G protein-coupled metabotropic glutamate receptors (mGluRs). These compounds permit photo-agonism of G i/o -coupled group II mGluRs with near-complete efficiency relative to saturating glutamate when attached to receptors via a range of orthogonal, multiplexable modalities including SNAP-, CLIP-, and Halo-tags, as well as via receptor-targeting nanobodies. Through a chimeric approach, branched ligands also allow efficient optical control of G q -coupled mGluR5 with precise, dynamic subcellular targeting. Finally, branched ligands enabled the development of dual photoswitch-fluorophore compounds that allow simultaneous imaging and manipulation of receptors via the same attachment point. Together this work provides a new design framework for photoswitchable ligands and demonstrates a toolset suitable for quantitative, mechanistic study of neuromodulatory receptors at the molecular, cellular and circuit levels.
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Introduction:
Pharmacological studies have provided a foundation for our understanding of the molecular basis of biological function, particularly with regard to membrane receptors 1 . However, shortcomings in the spatiotemporal precision at which drugs can be added and removed from a preparation, the paucity of drugs which unambiguously distinguish between molecular subtypes, and the inability to target drug action to genetically-defined cell types limits the mechanistic insight that can be gleaned from such studies. In recent years, photopharmacology has emerged as an alternative approach where lightdependent chemical cages, such as 4-methoxy-7-nitroindolinyl (MNI), or photoswitches, such as azobenzenes, are conjugated to established compounds to allow light to control ligand efficacy and thus afford the system with improved spatial and temporal precision 2 .
When such chemical photoswitches are covalently tethered to a protein target they facilitate the highest degree of specificity, spatial and temporal control and, through genetic targeting of the protein target itself, allow drug action to effectively be limited to defined cell types within physiological systems 3 . By tethering the ligand to a specific tag, the subtype specificity problem is solved at the level of attachment rather than at the ligand binding site, enabling native ligands to serve as the functional group without concerns about off-target pharmacological effects. Genetic encoding of the target protein can also, in principle, facilitate the incorporation of receptor variants or mutants to test their role in a physiological context. While earlier studies used native nucleophiles 4 or engineered cysteines [5] [6] [7] or reactive unnatural amino acids 8 for tethering, we recently introduced photoswitchable, orthogonal, remotely-tethered ligands ("PORTLs") which attach to a genetically-encoded self-labeling tag (i.e. SNAP), enabling efficient and orthogonal labeling of the protein target 9, 10 .
G protein-coupled receptors (GPCRs), the largest family of membrane receptors in eukaryotes and the largest class of drug targets 11, 12 , are particularly well-suited to tethered photopharmacology. Many receptor subtypes for the same ligand often exist and due to their highly conserved binding sites, developing specific agonists and antagonists remains a major challenge. Furthermore, the cellular and physiological complexity of GPCR signaling, especially in the nervous system where they signal in distinct spatially-delimited contexts such as the synapse, and in distinct cell types within neural circuits, highlights the limitations of traditional pharmacology. The metabotropic glutamate receptors (mGluRs) form a family of neuromodulatory GPCRs which respond to the excitatory neurotransmitter glutamate to control neuronal excitability and synaptic strength in many different brain regions 13 . These central roles in neuronal signaling have allowed the eight mGluRs to emerge as highly attractive drug targets for disorders ranging from psychiatric and neurological disease to cancer 14 , but deciphering their underlying mechanisms has proven to be challenging, limiting our understanding of both their fundamental signaling properties and the basis for their roles in disease. Azobenzene-glutamate PORTLs were initially developed for N-terminally SNAP-tagged mGluR2 9, 10 where they have been shown to effectively turn mGluR2 signaling on and off with sub-second precision for applications in cultured cells 15 and in the retina of behaving mice 16 . While this system represents one of the most efficient tethered photoswitch systems characterized to date, many limits still exist including incomplete efficacy of the photoswitch relative to glutamate, the inability to visualize labeled receptors, and the lack of validation of the technique in intact brain tissue. In addition, extending the PORTL approach to other mGluR subtypes has been a major challenge that has so far limited this approach primarily to analysis of mGluR2.
Here we sought to develop strategies to enhance the efficiency and applicability of PORTLs, with a focus on mGluRs. Following mechanistic characterization of the determinants of PORTL efficiency where we discover the importance of flexibility of the self-labeling protein tag, we introduce and characterize a family of branched, tethered azobenzene-glutamate photoswitches that allow for photoagonism of mGluR2 with near-complete efficacy relative to glutamate. We successfully design and characterize branched PORTLs for SNAP, CLIP, Halo and nanobody-based labeling strategies. The branching approach also allows for high-efficiency optical control of mGluR3, which previously showed minimal light responses with single-branch PORTLs 10 , and of mGluR5 through a chimera strategy. We use this approach for control and spatiotemporal analysis of mGluR5-induced calcium oscillations and demonstrate the use of this tool to control mGluR5 signaling in astrocytes, where we find evidence for confinement of calcium responses to processes. Finally, the branching framework allows for the development of a first generation of dual photoswitchable ligand/fluorophore compounds that permit simultaneous optical control and sensing of mGluR2 in cortical brain slices. Together this work introduces a diverse toolset of multiplexable, photoswitchable mGluRs and a generalizable strategy for enhancing the efficiency of tethered and photoswitchable ligands.
Results:

SNAP-tag flexibility, not linker composition, is a major determinant of tethered photoswitch efficiency
We initially focused on a mechanistic analysis of the prototypical system of benzylguanineazobenzene-glutamate ("BGAG n " where n=number of PEG repeats between BG and azobenzene) conjugated to SNAP-mGluR2 ( Fig. 1a) . We previously analyzed the role of BGAG length and found that a similar 50-60% photoswitching efficiency was observed in compounds ranging from BGAG 0 to BGAG 12 , but that beyond 12 PEG repeats the efficiency starts to decrease 10 . The lack of clear lengthdependence over a wide range raised the questions of what other parameters determine photoswitch efficiency. We probed the role of the distance and orientation between PORTL attachment and ligand binding sites by analyzing the linker between the self-labelling SNAP-tag and the mGluR2 ligand binding domain. We added two, four or six flexible glycine-glycine-serine ("GGS") repeats or removed the existing threonine-arginine ("TR") linker along with the C-terminal glycine-leucine-glycine ("GLG") motif of SNAP. For each construct we determined BGAG 12 efficiency relative to glutamate by measuring G protein-coupled inward rectifier potassium (GIRK) channel activation in HEK 293T cells using whole cell patch clamp electrophysiology ( Fig. 1b; Fig S1a, b) . The system tolerated either the complete removal of the linker or the addition of up to 4 GGS repeats, but a decrease in efficiency was observed with 6 GGS repeats ( Fig. S1c) . We also tested SNAP-(GGS) 6 -mGluR2 with short (BGAG 0 ) and long (BGAG 28 ) variants and found that in all cases a clear reduction in efficiency was seen ( Fig. S1d, e ). The tolerance of the system for a wide range of linker lengths means that there likely is not a precise optimal linker or photoswitch length for fine-tuning photoswitch efficiency.
We next turned to the SNAP-tag itself as a potential source of photoswitch modulation. SNAP was evolved from a human alkyltransferase and many variants exist with different biophysical and labeling properties [17] [18] [19] [20] [21] . All existing SNAP-mGluR photoswitching has been based on the SNAP26m variant which is referred to simply as SNAP in this study. We decided to test the "SNAPfast" (SNAP f ) variant which is defined by an increased affinity for a broader substrate profile. Surprisingly, BGAG 12 photoswitch efficiency was drastically reduced with SNAP f -mGluR2 ( Fig. S2a, b ; efficiency= 31.9 ± 5.0% for SNAP f ; unpaired t-test versus SNAP, p=0.0007) and BGAG 0 switching was nearly abolished ( Fig. S2c, d ). Based on its increased intramolecular interactions 22 , we hypothesized that SNAP f provides a less flexible attachment point which constrains the conformational landscape of BGAG limiting its ability to access the glutamate binding site. We tested this with single molecule Förster resonance energy transfer (smFRET) measurements of detergent-solubilized, surface-immobilized SNAP-mGluR2 or SNAP f -mGluR2 dimers ( Fig. S3a-b) 23 . In the presence or absence of 1 mM glutamate, histograms of FRET values measured from individual molecules showed sharper peaks for SNAP f -mGluR2 compared to SNAP-mGluR2 ( Fig. S3c-f ), suggesting that labelled SNAP f is indeed more rigid than SNAP. Together these data point to flexibility of the labeling tag itself as a determinant of PORTL photoswitch efficiency.
The flexibility of SNAP may also explain how BGAG 0 , a short ligand with a limited reach, is able to provide efficient photoactivation. Furthermore, this finding should also inform the application of SNAP tags for conformational studies or the development of biosensors.
Branched BGAGs enable near-complete optical control of SNAP-mGluR2
Despite optimization of BGAG length, inter-domain linkers and SNAP variants, a photoswitch efficiency of ~50-60% appeared to be an upper limit for the system (Fig. 1b) . We sought a strategy to improve this efficiency. Following illumination, azobenzenes reach a photostationary state (PSS) with a certain proportion of molecules populating the high-energy cis-isomer. At optimal wavelengths, typically 80-90% of bis-acylated 4,4'-diaminoazobenzene scaffolds are able to populate the cis-state 24 . When factoring in mGluR2 cooperativity 15 , this 80-90% photoisomerization translates to ~60-80% photoswitch efficiency, even with 100% labeling efficiency ( Fig. S4a) . Based on this, we reasoned that a molecule with two azobenzene groups and, thus, two independent chances of photoisomerization would increase the photoswitch efficiency. Since the azobenzene glutamate head group is the pharmacologically active part of BGAGs, we envisioned a branched molecule containing two azobenzene glutamates ( Fig. 1c) .
Indeed, when we calculated the expected photoswitch efficiencies for hypothetical "doubleBGAG" molecules across a range of systems of different cooperativities we predicted clear improvements across all photostationary states ( Fig. S4a ) and over all labeling efficiencies ( Fig. S4b) . When we used our most likely scenario of mGluR2 cooperativity with a PSS of 85% and labeling efficiency of 90%, we estimated that "doubleBGAG" would substantially enhance photoswitching efficiency to >80% ( Fig. S4c, d) . It is worth noting that these calculations do not take into account any potential changes of the local, effective glutamate concentrations which, in principle, should double for such compounds.
The design of branched BGAGs is based on previously described BGAG compounds to maintain an efficient synthetic pipeline, and BG-COOH was chosen as the functionalizable bioconjugation motif for SNAP (Scheme S1). Next, the branching moiety and point had to be considered. Since the azobenzene is linked to the PEG chain by a glycine linker, we anticipated that an additional branching amino acid would not significantly prolong the attachment chain. Fmoc-glutamate thus appeared well-suited and was reacted as its doubly-activated NHS ester with two azobenzene glutamate precursors (Scheme S2). After Fmoc deprotection, the PEG 12 chain was installed and finally conjugated to BG to obtain doubleBGAG 12 ("dBGAG 12 ") ( Fig. 1d ; Scheme S2). dBGAG 12 showed similar photophysical properties compared to BGAG 12 (Fig. S5a, b ) and similarly efficient labeling of SNAP-mGluR2 ( Fig. S5c) . When conjugated to SNAP-mGluR2, dBGAG 12 enabled optical control of mGluR2 with nearly complete efficiency relative to saturating glutamate ( Fig.   1e , f). As predicted ( Fig. S4b) , even at decreased labeling efficiencies dBGAG 12 enhanced photoswitch efficiency ( Fig. S6a, b ). Facile tuning of photocurrent amplitude was permitted by varying the illumination wavelength ( Fig. S6c) . In addition to enhancing overall efficiency, dBGAG 12 also produced faster optical activation of mGluR2 ( Fig. 1g ) likely due to either a critical amount of active cisconformers being reached more quickly or faster downstream signaling due to more complete population of the receptor's active state.
To test if the enhanced efficiency of dBGAG 12 would be maintained in a more complex, physiological environment with native effectors, we turned to cultures of cortical neurons. Following transfection of SNAP-mGluR2, photoactivation with either dBGAG 12 or BGAG 12 led to robust hyperpolarization and decreased neuronal firing, but the magnitude of the effect was larger for dBGAG 12 ( Fig. 1h-j) . dBGAG 12 -mediated photo-activation was bistable ( Fig. S6d ) and substantially faster in neurons compared to HEK 293T cells (t on = 0.30 ± 0.10 s and t off = 0.48 ± 0.07 s in neurons, n= 12 cells).
Confirming that the rapid light-induced hyperpolarization was indeed mediated by mGluR2 activation, the group II mGluR antagonist LY341495 was able to fully abolish light-induced effects on membrane potential ( Fig. S6e ). Together these experiments show that dBGAG 12 -mediated optical control of mGluR2 is well-suited to studies in the native neuronal context.
Given the utility of branched BGAGs, we decided to further characterize this new approach. We first asked if the presence of two azobenzene-glutamate moieties would lead to increased basal activation of mGluR2 by trans-dBGAG 12 in the dark. Application of a saturating concentration of LY341495 had a marginal effect on baseline current which was identical for unlabeled, BGAG 12 -or dBGAG 12 -labeled SNAP-mGluR2, indicating that there is minimal basal receptor activation in all systems ( Fig. S7a-b ). We also photoisomerized dBGAG 12 in the presence of glutamate and, as was reported for BGAG 12 , did not observe any current decrease ( Fig. S7c) , consistent with dBGAG 12 serving as a full rather than a partial agonist. To probe the effective concentration of the glutamate groups of dBGAG 12 , we analyzed photoswitching in SNAP-mGluR2-R57A, a low affinity variant that we previously characterized with BGAG 0 and BGAG 12 10 . Whereas single chain BGAG variants showed no photoactivation in this mutant, small but detectable photoactivation was observed with dBGAG 12 (Fig. S7d, e ) confirming that the local concentration is increased with this PORTL. Based on the concentration-dependence of this mutant, we estimate that dBGAG 12 mimics a local glutamate concentration of ~100 µM. In addition to weak photoactivation in the absence of glutamate, dBGAG 12 also showed large photocurrents in the presence of sub-saturating 1 mM glutamate ( Fig. S7d, e) , consistent with previous studies showing cooperativity where agonizing two subunits produces substantially larger activation than agonizing one 15 . These experiments show that dBGAG 12 only weakly increases the local concentration of the tethered azobenzene-glutamate on mGluR2, supporting PSS-based enhancements ( Fig. S4 ) as the main contributor to the improved photoswitching.
We next explored the specific composition of the branched PORTL by synthesizing the following branched BGAG variants: a short variant dBGAG 0 (Scheme S3), dBGAG 12,v2 (Scheme S4) where the branch point is placed just after the BG and, thus, two 12-repeat PEG chains are included in the compound, and qBGAG 12 (Scheme S5) where four azobenzene-glutamates are added in parallel.
dBGAG 12,v2 permitted high-efficiency photoactivation of SNAP-mGluR2 to the same level as dBGAG 12 ( Fig. S8a) , indicating that the branch location is not a critical parameter. Similarly, qBGAG 12 also showed high efficiency photoactivation but did not allow any further enhancement ( Fig. S8b) , likely due to the fact that the proportion of subunits with a cis-azobenzene is already at saturation in dBGAGs ( Fig. S8c) .
In contrast, and despite the robust photoswitching seen with BGAG 0 , dBGAG 0 provided photoactivation of SNAP-mGluR2 with only ~20% efficiency ( Fig. S8d) . This result suggests that branching may restrict the conformational freedom of BGAGs and, in the case of the short dBGAG 0 , this entropic cost reduces the efficiency of ligand binding.
Together these data provide a strategy for enhancing optical control of SNAP-mGluR2. To see if this branching-based strategy would also improve a less optimal PORTL system, we tested dBGAG 12 on SNAP f -mGluR2 and observed a clear improvement in photoswitch efficiency from ~30% to ~50% ( Fig.   S8e, f) . Given the robust improvement in photoswitch efficiency afforded by branched BGAGs on SNAPbased PORTLs, we next wondered if the strategy of branching could be generalized to other mGluR2targeting PORTLs.
Generalization of branched PORTLs to other labeling modes and spectral variants
A major advantage of the PORTL system is the ability to design and synthesize new PORTLs by flexible mix-and-matching of different chemical moieties ( Fig. 2a) . We hoped that this modularity would enable a toolset of photoswitchable mGluR2 variants optimized for different applications based on the desired attachment chemistry or spectral properties. To enable high efficiency optical control of mGluR2 tagged with CLIP, a variant with orthogonal labeling to SNAP 25 , we synthesized "doubleBCAG 12 " (dBCAG 12 ) (Scheme S6). Similar to dBGAG 12 , dBCAG 12 enabled near-complete optical control of CLIP-mGluR2 ( Fig. 2b-d) . Branching did not alter the specificity of dBCAG 12 , which showed no photocurrent when applied to cells expressing SNAP-mGluR2 (2.8 ± 0.3% relative to 1 mM glutamate, n=3 cells;
labeled at 1 µM).
With the goal of further expanding the repertoire of PORTLs to a third self-labelling, orthogonal suicide enzyme, we aimed to implement the Halo-tag. The Halo-tag is an evolved dehalogenase that reacts specifically with alkyl chlorides to form a covalent bond 26 . Compared to BG and BC substrates, alkyl chlorides offer better permeability, a smaller and more physiological side product in chloride and higher acid stability, the latter which simplifies synthetic protocols. As such, we first synthesized the terminal alkyl chloride bearing ClAG 12 (Scheme S1, S7) and cloned an N-terminally Halo-tagged mGluR2 construct. Based on the hypothesis that branching Halo-targeting PORTLs would enhance photoswitching, we also synthesized "doubleClAG 12 " (Scheme S8; Fig. 2e ). Both PORTLs showed photoactivation of mGluR2 with identical spectral properties to BGAGs and BCAGs ( Fig. 2f) , but the efficiency of photoactivation of Halo-mGluR2 was boosted by branching with dClAG 12 (Fig. 2f, g) . This result introduces the Halo tag to the branched PORTL approach and expands the toolkit to three distinct, orthogonal protein tags.
A key advantage of azobenzene-based photoswitches is the ability to tune the photochemical properties of the compound. The previously reported red-shifted BGAG 12,460 allows for visible-light induced, fast-relaxing photoactivation of mGluR2 which is advantageous in some settings, including for vision restoration applications 16 . To test if branching would also enhance PORTLs with a distinct azobenzene core, we synthesized "doubleBGAG 12, 460 " and observed enhanced visible light photoactivation of SNAP-mGluR2 (Scheme S6; Fig. 2h-j) .
Finally, a long-term goal of tethered photopharmacology is to incorporate the optical control afforded by such compounds into antibody-mediated targeting of proteins. Along these lines, we recently reported a new entity termed nanobody-photoswitch conjugates (NPCs) consisting of a SNAP-tagged nanobody labeled with a PORTL. NPCs containing an anti-GFP nanobody are able to photoactivate GFPtagged mGluR2, albeit with limited efficiency 27 . We wondered if branched BGAGs would enhance the modest photoswitch efficiency observed with this system. Similar to all other systems tested, dBGAG 12 doubled the photoswitch efficiency of NPC-mediated photoswitching of mGluR2 ( Fig. S9) . This result further confirms that branched PORTLs are an effective general strategy for improving photoswitch efficiency that should facilitate the further development and application of strategies for receptor targeting and optical control.
Branched PORTLs drastically enhance optical control of mGluR3
Throughout the nervous system a variety of receptors work in parallel to control glutamatergic signaling 13 . Given this molecular diversity, it is desirable to obtain the optical control of multiple mGluRs with high efficiency for comparative or multiplexed studies. Toward this goal, we turned to mGluR3, the other member of the group II mGluR subfamily. Despite the challenges in deciphering the unique properties of mGluR2 and 3 due to the paucity of subtype-specific drugs, recent work has found distinct activation dynamics 23 and subcellular localization 28 between receptor subtypes and a high propensity for heterodimerization between mGluR2 and 3 15 , raising the motivation for PORTLs to dissect the contributions of each group II mGluR subtype to biological processes. Previous work with BGAG PORTLs has shown only weak ~20% photoactivation of SNAP-mGluR3 with unbranched BGAGs 10 , precluding useful application of this tool. Unlike SNAP-mGluR2, SNAP-mGluR3 photoactivation shows steep length-dependence with the short variant, BGAG 0 , providing the highest efficiency. This suggests that mGluR3 photoactivation is limited, in part, by the local concentration of the azobenzene-glutamate moiety. We further characterized SNAP-mGluR3 photoswitching with unbranched BGAGs to see if SNAP-mGluR3 photoswitch efficiency could be enhanced by modifying the receptor construct. Neither
introduction of SNAP f to produce SNAP f -mGluR3 ( Fig. S10a, b ) nor addition of a flexible (GGS) 2 linker between SNAP and mGluR3 enhanced photoswitching with BGAG 0 or BGAG 12 (Fig. S10b) .
We next turned to branched BGAGs in the hope that the increased valence of the system along with the increase in the proportion of labeled subunits with a cis-azobenzene ( Fig. S4 ) would enhance the enable efficient photoswitching. Indeed, dBGAG 12 drastically improved photoactivation of SNAP-mGluR3 to levels comparable to SNAP-mGluR2 ( Fig. 3a-c) . To our surprise, neither dBGAG 0 or dBGAG 12,v2 were able to enhance photoswitch efficiency ( Fig. 3c ). It is difficult to account for the dramatically enhanced efficiency of branched PORTLs with either the increased proportion of subunits containing a cis-azobenzene or the modest, two-fold increase in local glutamate concentration.
Furthermore, the dependence on specific branching pattern suggests that the branch point introduces secondary interactions with the mGluR3 LBD that provide some binding enthalpy to drive photoagonism. Reducing the glutamate affinity of SNAP-mGluR3 by introducing an alanine at arginine 64, the homologous position to R57 in mGluR2, decreased but did not abolish dBGAG 12 photoswitch efficiency ( Fig. S10c, d) . This result suggests that, similar to the case with mGluR2, the glutamate moiety is in an effective concentration range of hundreds of micromolar. We also tested dBCAG 12 on CLIP-mGluR3 and observed drastically enhanced photoswitch efficiency compared to BCAG 12 (Fig. 3d-f) . Ultimately, the ability to optically control either mGluR2 or mGluR3 with either CLIP or SNAP-tags opens the door to dissecting their distinct functions in the nervous system.
Efficient optical control of mGluR5 signaling with spatiotemporal precision
We next turned to mGluR5, a group I mGluR that is highly expressed throughout the central and peripheral nervous systems. A limited and debated toolset of specific, orthosteric compounds for group I mGluRs exists 29 challenging the dissection of mGluR1 versus mGluR5 biology. Furthermore, mGluR5 is a prime target for PORTL-mediated control for a number of reasons. mGluR5 is expressed in a wide range of cell types within the brain, including excitatory principal cells, inhibitory interneurons and astrocytes, making it difficult to dissect the role of specific mGluR5 populations with global drug application or knock-out. While targeted knockouts have provided some insight 30, 31 , the ability to photoactivate mGluR5 in defined cell types would allow one to approach such questions with high precision and reversibility within neural circuits. Furthermore, mGluR5 has myriad signaling partners, interacts with an extensive network of scaffold proteins via its large C-terminal domain (CTD) and
couples to a variety of effectors and regulators 13 . PORTL-based control of mGluR5 would allow for the testing of receptor mutants in native systems to probe the role of specific interactions or regulatory sites.
For example, mGluR5 activation of G q is known to induce a unique form of calcium oscillations that are thought to be due to reversible protein kinase C (PKC)-mediated phosphorylation of a residue on the membrane-proximal part of the CTD 32, 33 . Finally, a deeper understanding of mGluR5 neurobiology is motivated by the roles of mGluR5 in long term synaptic depression and as a promising drug target for neurodevelopmental and neuropsychiatric disorders 34, 35 .
To date, group I mGluRs have not been successfully photosensitized with PTLs or PORTLs, likely due to pharmacological incompatibility of the azobenzene-glutamate moiety. However, we and others have shown that extracellular domains of mGluRs are portable and can effectively gate the TMDs of other mGluR subtypes 15 . With this in mind, we reasoned that a chimera between mGluR2 and mGluR5 that contains the entire TMD and CTD of mGluR5 would maintain the unique properties of mGluR5 signaling, while allowing efficient PORTL-mediated optical control.
We thus engineered a SNAP-mGluR2-5 chimera ( Fig. 4a) and observed similar glutamateevoked oscillatory calcium responses to mGluR5 in HEK 293T cells ( Fig. S11a) . SNAP-mGluR2-5
showed strong surface expression and the expected glutamate dose-response ( Fig. S11a, b) . We next tested if conjugation with BGAGs would enable photoactivation of mGluR5 signaling and found that, indeed, subcellular 405 nm illumination produced BGAG-dependent, repeatable, robust calcium oscillations ( Fig. 4b; Fig S11c, d) of a similar frequency to glutamate (1-3 oscillations/minute). In line with the enhanced efficiency of branched BGAGs on SNAP-mGluR2, light responses were more reliable, in terms of the percentage of cells that responded, for dBGAG 12 versus BGAG 12 (Fig. 4c) . Light-induced calcium oscillations were blocked by MPEP, an mGluR5 negative allosteric modulator ( Fig. S11e) , or enhanced by VU 0360172, an mGluR5 positive allosteric modulator ( Fig. S11f) , showing that the mGluR5 TMD maintains its native allosteric binding site within this chimera.
An important application of PORTL-mediated control of mGluR5 is the ability to probe specific functional aspects of mGluR5 rather than to merely control generic G protein signaling cascades, as is typically done with DREADDs or opsin-based tools 36 . To further test if mGluR5 identity is maintained in our system, we probed the role of the mGluR5 PKC phosphorylation site, Ser839, in induction of lightinduced calcium oscillations. Consistent with previous studies on mGluR5, mutation of Ser839 to alanine (S839A) nearly abolished the oscillatory response to both glutamate ( Fig. S12a, b ) and light ( Fig. S12c) in our construct.
To test the power of spatiotemporal control for the quantitative study of mGluR5 signaling, we next used targeted photoactivation to small regions of the cell to probe the properties of evoked calcium oscillations. We first asked if the size of the illumination spot was a determinant of response probability and observed that, indeed, increasing the area of photoactivation increased the probability of observing a calcium response ( Fig. 4d, e ). Fig. 4d shows an example cell where 3 different-sized, overlapping photoactivation areas were targeted; the smallest ROI failed to produce an intracellular calcium increase, the intermediate size elicited a single peak and the largest ROI produced an oscillatory response. Fig. 4e summarizes the photoactivation size-dependence of calcium responses and shows that ~25% of the cell was needed to have a 50% chance of a response. Consistent with previous work on mGluR5 37 , SNAP-mGluR2-5-induced calcium oscillation frequency was largely independent of the concentration of glutamate ( Fig. S13a, b) . Interestingly, in contrast to the weak effect of increasing glutamate concentration, it has been shown that increased receptor expression levels increase the frequency of calcium oscillations 37 . Given this, we asked if the area of photoactivation of a cell would lead to alterations in the calcium oscillation frequency. We varied the size of the photoactivation area and measured the subsequent calcium oscillation frequency and found that the frequency was largely insensitive to the proportion of the cell that was targeted ( Fig. 4f, g) . We also examined how calcium oscillations spread throughout the cell by comparing the calcium signal at the site of photoactivation to a distal part of the cell. Interestingly, both the temporal profile ( Fig. S13c ) and calcium response amplitude (100.6 ±13.5 % of the amplitude at the activation site, n= 6 cells) were maintained at the distal site.
Furthermore, we were able to use the offset in signals to calculate a calcium wave velocity for each cell of 10-20 µm/s (Fig. S13d) , which is comparable to prior measurements of spontaneous calcium waves in mammalian cells 38 .
One of the key mechanisms by which mGluR5 signaling is thought to modulate neural activity is through signaling within astrocytes, especially in the developing brain 39, 40 . Astrocytic mGluR5 can respond to synaptic glutamate to control astrocyte calcium signaling dynamics, gliotransmission and morphology [41] [42] [43] , but the inability to isolate astrocytic mGluR5 signaling from neuronal mGluR5 signaling has hampered progress on the underlying mechanisms of this form of neuromodulation. As previously reported, cultured astrocytes from mouse hippocampus and cortex showed calcium elevations in responses to mGluR5 activation [44] [45] [46] , with a mix of single peaks and oscillations ( Fig. S14a-c) . We next asked if our photoswitchable mGluR5 system could allow us to mimic native mGluR5 responses and permit the use photoactivation to probe this system. Photoactivation of dBGAG 12 -labeled SNAP-mGluR2-5 in astrocytes initiated either single peaks or calcium oscillations ( Fig. 4h; Fig. S14d, e ) of higher frequency than in HEK cells (3-6 oscillations/minute). In the absence of the receptor construct, no light responses were observed ( Fig. S14f) . Targeted photoactivation to small areas revealed signal spreading heterogeneity between the soma and extended processes that was different from what was observed in the spatially-homogenous HEK 293T cells. When photoactivation was targeted to the soma, oscillations were observed in the soma in ~55% of cells of those responding cells and oscillations were observed in at least one process in ~50% of those cells (Fig. S14g) . However, when photoactivation was targeted to a process, local oscillations were observed at the targeted process in ~65% of cells but were only seen in the soma in 15% of those cells ( Fig. 4h; S14h) , consistent with previous observations of global or compartmentalized calcium responses in astrocytes 47 . In addition, oscillations were of a higher frequency in the processes compared to in the soma (6.9 ± 0.8 oscillations/minute in processes vs. 4.5 ± 0.7 oscillations/minute in soma; n= 4 cells where both sites were targeted). Together this work demonstrates the suitability of our approach for probing mGluR5 signaling dynamics in astrocytes and motivates future applications to dissect the contribution of neuronal versus astrocytic mGluR5 signaling to synaptic and circuit-level processes.
Dual photo-activation and imaging with branched PORTL/fluorophore compounds
Optogenetic actuators, such as the PORTL-based control of mGluRs described here, are powerful tools for dissecting the molecular basis of biological processes. However, a complete understanding of the underlying molecular events also requires precise sensing of protein localization and/or conformation.
Combining the ability to optically manipulate and sense the same receptor population would be a particularly powerful means of obtaining a full picture of receptor function. Chemical conjugation of expressed proteins with organic fluorophores produces brighter fluorescence compared to fluorescent proteins, allows one to maintain flexibility for using different spectral variants with the same protein target and permits surface versus intracellular targeting 48 . Combining attachment of fluorophores and photoswitch actuators to the same receptor population would enable the simultaneous study of receptor localization and/or conformational state while controlling its activity, a potentially very powerful technique.
Given our demonstration that SNAP-tagged receptor targets tolerate PORTL branching, we decided to test if incorporation of a fluorophore into a branched BGAG would enable dual optical manipulation and detection. As such, we chose the same branching point endowed with a fluorophore instead of a second azobenzene-glutamate. The fluorophore should be spectrally orthogonal to switching wavelengths, rendering Cy5 with its absorption/emission wavelengths in the far-red (650/670 nm) perfectly suited. Accordingly, Cy5 was installed on the e-amine of lysine, and whose acid was coupled to the azobenzene-glutamate before linking to BG and a PEG 12 chain to obtain "BGAG 12 -Cy5" (Fig. 5a; Scheme S8). BGAG 12 -Cy5 showed an expected absorption spectrum with peaks for both the azobenzene and Cy5 (Fig. S15a) , and showed efficient labeling of SNAP-mGluR2 over the same concentration range as other BGAGs (Fig. S15b) . Most importantly, BGAG 12 -Cy5 permits efficient optical control of SNAP-mGluR2, while also allowing imaging of the receptor on the plasma membrane of cells ( Fig. 5b; Fig.   S15b ). The photoswitch efficiency and kinetics were indistinguishable from BGAG 12 alone (Fig. S15c) ,
indicating that the incorporation of Cy5 did not alter the pharmacology of the azobenzene-glutamate. Cy5 into the medial prefrontal cortex (mPFC) of mice in only one hemisphere. The mPFC was targeted because this is an area of native mGluR2 expression 49 and because of its involvement with many of the psychiatric disorders for which mGluRs are implicated. Confocal images demonstrate clear targeting of SNAP-mGluR2 by BGAG 12 -Cy5 with no background labeling in mice infected with FLEX-SNAP-mGluR2 but not the CaMKII: Cre virus (Fig. 5d) . This demonstrates the suitability of branched PORTLs for in vivo labeling of SNAP-tagged receptors without background. We then performed patch clamp recordings from slices prepared from injected mice. The fluorescence from BGAG 12 -Cy5 allowed for the easy identification of the site of receptor expression and labeling. We recorded from fluorescent cells in the injected hemisphere and non-fluorescent cells in the control hemisphere of the medial PFC and observed a light-induced hyperpolarization only in the fluorescent hemisphere (Fig. 5d ). In addition, photoactivation of mGluR2 produced a reversible, repeatable decrease in spike firing in response to current injection (Fig. 5e) . The modest 2-5 mV hyperpolarization and decreased excitability observed was similar to what is typically seen for endogenous or heterologously-expressed G i/o -coupled receptors in cortical pyramidal cells 50, 51 . Importantly, no light responses were observed in slices from wild type mice injected with BGAG 12 -Cy5 ( Fig. S15d) and expression and labeling of SNAP-mGluR2 did not alter the resting membrane potential of neurons ( Fig. S15e) . Notably, previous drug application-based slice studies of GPCRs have provided minimal information on the kinetics and repeatability of receptor effects, likely due to long bath exchange and tissue penetration times on the seconds to minutes time scales. Here, photo-activation of SNAP-mGluR2 revealed rapid on and off kinetics on the hundreds of milliseconds time scale (t ON = 330 ± 41 ms, t OFF = 687 ± 64 ms; n= 13 cells) and clear reproducibility over many cycles ( Fig. S15f) , showing the utility of photoswitchable ligands for dissecting the precise timing of neuromodulatory processes in intact tissue. Together this demonstrates the utility of the bi-functional fluorophore/PORTL approach and provides a framework for using branching to further expand the world of PORTLs and PORTL-based applications.
Discussion: Branched PORTLs: A new strategy for high efficiency optical control and dual control and detection
Despite their emergence as useful tools for studying membrane receptor signaling, the applicability and generalizability of tethered photoswitches has remained limited by both a lack of understanding of the underlying mechanisms and a limited number of strategies for enhancing optical control of a given target. Here we report a family of branched, tethered photoswitchable ligands that enhance the efficiency of existing photoswitchable receptors (i.e. mGluR2) and enable extension of the approach to other, related targets (i.e. mGluR3, mGluR5). We show that a primary effect of branching is to increase the number of azobenzene moieties that reach the active cis-state. This effect overcomes the limitations of the incomplete cis occupancy achieved at all photostationary states and should be useful for a wide range of probes, including soluble photochromic ligands 2 . Furthermore, this re-design highlights the fact that cooperative, multimeric receptors which show non-linear ligand-occupancy dependent activation pose major obstacles to achieving high efficiency optical control. As a secondary effect, branching enhances the local concentration of the functional group which likely also contributes to the enhanced efficiency of the pharmacophore. This effect indicates that branching should be useful for all tethered ligand approaches, even those that do not incorporate photosensitivity [52] [53] [54] .
As a complement to our implementation of branched PORTLs, we also provide new insight into the mechanisms of tethered photoswitches. Along with previous studies 9, 10 , we have found that in the case of SNAP-mGluR2 there is a tolerance for a wide range of PORTL lengths and lengths of the linker between the SNAP-tag and the receptor. In contrast, we find that tag flexibility itself is a key parameter needed when assessing self-labeling protein tags and their ability to be employed for PORTLs. Together these observations indicate that the efficiency of photoswitching is determined by the relative energetic contributions of the enthalpy change associated with binding of the active form of the functional group and the associated entropy loss of the protein tag and PORTL linker, similar to what has previously been described for a tethered enzyme inhibitor 55 . Further work focused on the pharmacology of the tethered ligand itself is needed to understand why different subtypes photoswitch to different degrees or with different directionality and should provide a further means of optimization.
The PORTL approach incorporates the spatiotemporal precision of light, genetic targeting, and receptor subtype-specificity. Furthermore, the use of full length receptors gives the ability to incorporate mutations to alter activation mechanism, effector coupling or regulation. Here we report high efficiency photoactivation of mGluR2 via branched PORTLs which target SNAP, CLIP or Halo tags and have different spectral properties. We also report that dBGAG 12 We used the spatiotemporal precision of this system to probe the nature of mGluR5-induced calcium oscillations. Unlike typical GPCR-induced calcium oscillations which are thought to be largely driven by cycles of IP 3 receptor desensitization and re-sensitization 57 , mGluR5-induced calcium oscillations are dependent on reversible phosphorylation of a PKC site (S839) 32, 33 , which is maintained in our construct. Here we find that neither glutamate concentration, as previously reported 37 , nor the proportion of the cell that is photoactivated alters the frequency of calcium oscillations. This suggests that beyond a response threshold, which we calculate as either ~1 µM glutamate or activation of ~25% of the cell, calcium oscillations occur at an intrinsic frequency for any given cell. This essentially turns mGluR5 into a binary switch rather than a dial, as receptor responses are normally modeled. What determines this intrinsic frequency? One possibility is that it is merely determined by the relative densities of receptors, G proteins, protein kinase C, phosphatases and other factors that shape G protein turnover and calcium handling. Altering the proportion of the cell that is activated or the glutamate concentration does not effectively change these ratios, only altering the density of each component does. This is consistent with a previous report that increasing the expression of receptors can increase the frequency of calcium oscillations 37 . Future work is needed to understand the mechanisms that determine calcium oscillation properties and how these oscillations are decoded by downstream process, such as transcription.
We also demonstrate mGluR5 photoactivation in astrocytes, where we find similar oscillatory responses following receptor activation, but clear evidence that different sub-domains of the cell appear to confine calcium oscillations. Most strikingly, we find that activation of mGluR5 in astrocytic processes often produced local calcium oscillations that did not travel to the soma. This suggests that synaptic glutamate may induce local calcium responses that do not spread globally throughout the cell, perhaps to maintain input specificity. Consistent with this notion, imaging of spontaneous signals in astrocytes has led to numerous examples of calcium waves which remain confined either within processes or smaller microdomains 47 . In the case of mGluR5 activation, determining the mechanism of signal confinement will require the identification and study of the relevant effectors, calcium sources and scaffolding proteins.
Notably, Arizono et al 58 found that astrocytes mGluR5 translocates more rapidly in processes than in the soma and that a diffusion barrier prevents exchange of receptors from the processes back to the soma.
Together, these experiments demonstrate the power of PORTL-based optical control for a quantitative dissection of receptor-induced cell signaling dynamics with a precision not afforded by soluble ligands.
Methods
Chemical Synthesis
See Supporting Information for details on chemical synthesis and characterization.
Single Molecule FRET
Single-molecule Förster resonance energy transfer (smFRET) experiments were performed on an inverted microscope (Olympus IX73) in total internal reflection (TIR) mode using a 100x objective (NA=1.49) and a 561 nm laser diode. Movies were recorded simultaneously with two sCMOS ORCA-Flash4 v3.0 cameras (Hamamatsu) separated by a 635 nm long-pass dichroic mirror and with appropriate emission filters for donor (595/50) and acceptor (655LP). A microflow chamber was assembled using a passivated glass coverslip prepared with mPEG-SVA and biotinylated PEG (MW=5000, 50:1 molar ratio, Laysan Bio) as previously described 23 . The microflow channels were first incubated with 0.2 mg/ml of NeutrAvidin (ThermoFisher) for 2 min, followed by 10 nM of biotinylated secondary donkey anti-rabbit, antibody (ThermoFisher, A16039) for 30 min, and 10 nM of anti-Metabotropic Glutamate Receptor 2+3 antibody (abcam, ab6438) for 30 min. Microchannels were washed 5 times between each conjugation step with T50 buffer (10 mM Tris, 50 mM NaCl, pH 8).
Following 48 hr expression of either HA-SNAP-mGluR2 or HA-SNAP f -mGluR2, HEK293T cells were labeled for 1 hour at 37 °C using a 1:3 molar ratio of BG-LD555 (1 µM) and BG-LD655 (3 µM) dyes (Lumidyne Technologies) dissolved in EX buffer containing (in mM): 10 HEPES, 135 NaCl, 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 . After labeling, cells were washed 2 times with EX buffer, harvested by incubating the cells in PBS (Ca 2+ and Mg 2+ free) for 20 min, and lysed for 1 hr at 4 °C using lysis buffer containing (in mM): 150 NaCl, 1 EDTA, protease inhibitor cocktail (Thermo Scientific) and 1.2% IGEPAL detergent (Sigma). Finally, cell lysates were spun down at 16,000 x g for 20 min at 4 °C, supernatant was collected, and maintained on ice prior to imaging. Protein samples were diluted using a dilution buffer (EX containing 0.1% IGEPAL) and added to the microflow chamber until the density reached ~400 molecules per 2,000 µm 2 . Any unbound proteins were washed using the dilution buffer.
Single molecule fluorescence movies were recorded at one frame per 100 ms in the presence of an oxygen scavenging system (1 mg/ml glucose oxidase, 0.04 mg/ml catalase, 0.8% w/v D-glucose) and
photostabilizing agents (5 mM cyclooctatetraene). smFRET data analysis was performed using SPARTAN 59 . FRET histograms (averaged from 3 separate movies per condition) were then plotted and fitted using a single Gaussian function to get a peak position and FWHM.
Molecular Cloning, Cell Culture, and Gene Expression
Experiments were performed using previously described N-terminally SNAP-or CLIP-tagged rat or human mGluRs 60 . Mutations, insertions, and deletions were introduced using standard PCR-based techniques. SNAPfast or Halo were introduced into mGluR2 at the same position as SNAP using Gibson assembly. The chimeric SNAP-mGluR2-mGluR5 was made, also via Gibson assembly, using the extracellular domain of SNAP-tagged mGluR2 (K23 to E559) and rat mGluR5 transmembrane domain and C-terminal domain (Y571 to STOP). For adeno-associated virus production, SNAP-mGluR2 was cloned into a previously described FLEX construct (addgene ID: 26966).
HEK 293T cells (authenticated by Bio-Synthesis, Inc. and tested negative for mycoplasma using a kit from Molecular Probes) were plated at low density on poly-L-lysine coated coverslips (18 mm) and transfected the following day using either Lipofectamine 2000 or 3000 (Thermo Fisher). 24-48 hrs after transfection, cells were used for electrophysiology or imaging experiments. As previously described 10 Neu-N and Iba1 staining was performed on a subset of coverslips, but no positively labeled cells were observed. >90% of GCaMP6 positive cells showed co-labeling with glutamine synthetase, confirming their identity as astrocytes.
HEK Cell and Cultured Neuron Electrophysiology
Whole cell patch clamp recordings from HEK 293T cells were performed 24-48 hours after transfection as previously described 27 . Briefly, voltage clamp recordings at -60 mV were performed in a high potassium (120 mM) solution to enable large inward currents upon receptor activation. Unless otherwise noted, cells were incubated with 1-10 µM of PORTL for 45-60 min at 37 °C in the appropriate extracellular recording solution. Labeling efficiency was determined as previously described 10 . Illumination was applied to the entire field of view using a CoolLED pE-4000 through a 40×
objective. Light intensity in the sample plane was 1-2 mW/mm 2 . pClamp software was used for both data acquisition and control of illumination.
Calcium Imaging
HEK 293T cells were imaged at 30 °C in extracellular solution containing (in mM): 135 NaCl, 5.4 KCl, 10 HEPES, 2 CaCl 2 , 1 MgCl 2 , pH = 7.4 with continuous perfusion on a Zeiss LSM880 scanning confocal microscope using ZEN Black software with a 63x objective, a 488 nm laser for imaging and a 405 nm laser for photoactivation. For photoactivation experiments, a brief 10-100 µM glutamate application was used to identify healthy cells, based on calcium responses, which would be suitable for photoactivation experiments. Photoactivation was performed by scanning a 405 nm laser at 100% power in a defined region for 40 iterations between each imaging frame. For drug application experiments, imaging was performed at room temperature on an Olympus IX-73 microscope using a 60x 1.49 NA APO N TIRFM objective (Olympus) and snapshots were taken with a sCMOS ORCA-Flash4 v3.0 camera (Hamamatsu).
GFP was excited with a 488 nm laser diode and glutamate was added by a gravity-driven perfusion system.
Astrocytes were imaged at 37 °C with the same protocol described above in an extracellular solution containing (in mM): 138 NaCl, 1.5 KCl, 1.2 MgCl 2 , 2.5 CaCl 2 , 10 glucose and 5 HEPES, pH 7.4. Process were defined as subcellular areas at least 15 µm from the nucleus where the thickness of decreased from that of the soma. ROIs for both analysis and photoactivation were maintained at ~60 µm 2 .
ROIs for photoactivation in processes were placed at least 15-20 µm from the soma. Oscillations were defined as more than one increase in intensity during a single application of UV or drug (at least one minute). DHPG was purchased from Tocris and applied using a gravity-driven perfusion system Image analysis was performed using ZEN (Zeiss) and ImageJ (Fiji). Intensities were normalized to baseline prior to photoactivation or glutamate application. Oscillation frequency was measured as the number of events per unit time. Ca 2+ wave velocity was calculated by first determining the time at 50% of the peak for both the photoactivation region of interest (ROI) and a secondary ROI of the same size (5 µm 2 ) on the other side of the cell (typically 15-30 µm away from the photoactivation ROI). The wave velocity was then calculated as the distance between the ROIs divided by the difference in time between 50% of the peaks.
Viral Expression and in vivo PORTL labeling
Male C57BL/6J mice were injected at p60 with either 1 µL of a 1:1 viral cocktail of AAV9-EF1a-FLEX- Brains were mounted and frozen at -20 °C in OCT block and medial prefrontal cortex was sliced at 40 µm thick on a cryostat at -22 °C. Slices were wet mounted to glass slides and secured with coverslip using VECTASHIELD HardSet Antifade Mounting Medium with DAPI (Vector Laboratories). Glass slides were imaged using an Olympus Confocal FV3000 and images were processed in ImageJ.
Brain Slice Electrophysiology 14-18 hours following BGAG 12 -Cy5 injection, coronal slices of the medial prefrontal cortex were prepared at room temperature in an NMDG-HEPES aCSF containing (in mM): 93 NMDG, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 Glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 10
MgSO 4 , 0.5 CaCl 2 . Slices were maintained in this solution for ~10 min at 34 °C, and then allowed to recover for at least 45 minutes at room temperature in a modified aCSF containing (in mM): 92 NaCl, 2.5
KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 Glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 2 MgSO 4 , 2 CaCl 2 . Following recovery, slices were transferred to a modified superfusion chamber (Warner Instruments) and mounted on the stage of an Olympus U-TLUIR microscope.
Recording were performed at 30 °C in a standard oxygenated aCSF that continually circulated and bubbled with 95% O 2 /5% CO 2 containing: 124 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 24 NaHCO 3 , 5 HEPES, 12. 
